Aventis Behring L.L.C. Sustainability Profile
Aventis Behring L.L.C., a prominent player in the biopharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has established itself as a leader in the development and production of innovative therapies, particularly in the fields of immunology and haematology. Specialising in high-quality plasma-derived products, Aventis Behring is renowned for its commitment to patient safety and efficacy. Its unique offerings include immunoglobulins and clotting factor concentrates, which are critical for treating various rare diseases. With a strong market position, the company has achieved significant milestones, including regulatory approvals and partnerships that enhance its global reach and impact in the healthcare sector.
DitchCarbon Score
How does Aventis Behring L.L.C.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aventis Behring L.L.C.'s score of 38 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aventis Behring L.L.C., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is part of a corporate family that includes CSL Limited, from which it inherits climate commitments and performance metrics. Aventis Behring L.L.C. has not established its own reduction targets but aligns with the sustainability initiatives of CSL Limited. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded from CSL Limited. These initiatives reflect a broader commitment to reducing carbon emissions and enhancing sustainability practices within the industry. As a merged entity, Aventis Behring L.L.C. is expected to adhere to the climate strategies and performance standards set by CSL Limited, which may include ambitious targets for emissions reductions in the future. However, specific details regarding these targets or achievements have not been disclosed at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 250,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 58,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is Aventis Behring L.L.C.'s Industry?
How Carbon Intensive is Aventis Behring L.L.C.'s Location?
Aventis Behring L.L.C.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aventis Behring L.L.C. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
